主页文献库搜索
How is the relation between endocrine changes and bone markers in pediatric t...

Hamidieh(Amir A),Hamidi(Zohreh),Behfar(Mar... Minerva Pediatr 0000-00-00

...alkaline phosphatase and osteocalcin (bone formation markers), NTX (bone resorption marker), Ca, P, Alk ph, PTH, Vitamin...

Alteration of TGF-β-ALK-Smad signaling in hyperoxia-induced bronchopulmonary ...

Jin(Meihua),Lee(Juyoung),Lee(Kyung-Yup),Ji... Exp Lung Res 0000-00-00

...ALK1, ALK5, phosphorylated Smad1/5, phosphorylated Smad2/3, VEGF, and endoglin, as accessed by both biochemical and immu...

Society for Neuro-Oncology 2014 annual meeting updates on central nervous sys...

Lukas(Rimas V),Mehta(Minesh P),Lesniak(Mac... Neurooncol Pract 0000-00-00

...ALK-translocated non-small cell lung cancer are presented. Preclinical and clinical work on solid tumor leptomeningeal c...

Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasiv...

Shin(Dong Hoon),Lee(Donghoon),Hong(Dong Wa... Oncotarget 0000-00-00

...ALK fusion in additional two cases with NRG1 fusions. When comparing overall survival (OS) according to the presence of ...

Mesenteric inflammatory myofibroblastic tumors.

Chaudhary(Poras) Ann Gastroenterol 0000-00-00

...ALK) rearrangements and/or ALK1 and p80 immunoreactivity are reported in 33-67% of the tumors. Owing to the rarity of th...

ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of V...

Zer(Alona),Moskovitz(Mor),Hwang(David M),H... Clin Lung Cancer 0000-00-00

...ALK (anaplastic lymphoma kinase)-rearranged NSCLC.,We identified all patients with ALK-rearranged NSCLC diagnosed and/or...

Identification of driver mutations in tumor specimens from 1,000 patients wit...

Kris(M G),Johnson(B E),Kwiatkowski(D J),Ia... J Clin Oncol 0000-00-00

CRA7506 Background: The ability to detect driver mutations like EGFR and EML4-ALK in tumor specimens from patients with ...

Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patie...

Bang(Y),Kwak(E L),Shaw(A T),Camidge(D R),I... J Clin Oncol 0000-00-00

...ALK and MET/HGF receptor tyrosine kinases. EML4-ALK fusion oncogenes have been reported in approximately 4% of NSCLC. Pa...

BEAM-alemtuzumab followed by allogeneic SCT for the treatment of relapsed or ...

Repp(R),Günther(A),Schade(H),Humpe(A),Gahn... J Clin Oncol 0000-00-00

...ALK negative ALCL, 1 extranodal NK/nasal type and 1 enteropathy-type T-NHL. All patients had at least 2 different treatm...

Bony metastatic disease responses to sorafenib (BAY 43-9006) independent of P...

Dahut(W L),Scripture(C D),Posadas(E M),Wu(... J Clin Oncol 0000-00-00

...Alk Phos 108 u/l (48-259), Hb 12.7 g/dl (10.2-15.1). 60% of patients had received one prior chemotherapy regimen. Of the...

上一页 636 637 638 639 640 641 642 643 644 下一页 640 / 共 646

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com